Mahmood Al Kindi

Royal Adelaide Hospital, Tarndarnya, South Australia, Australia

Are you Mahmood Al Kindi?

Claim your profile

Publications (2)6.06 Total impact

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abnormalities in peripheral blood B cell subsets have been identified in common variable immunodeficiency (CVID) patients and classification systems based upon their numbers have been proposed to predict the clinical features. We analysed B lymphocyte subsets by multi-colour flow cytometry (MFC) in a cohort of well-characterized CVID patients to look at their clinical relevance and validate the published association of different classification criteria (Freiburg, Paris and Euroclass) with clinical manifestations. CVID patients had a reduced proportion of total and switched memory B cells (MBC, swMBC) compared to normal controls (P < 0·0006). Patients classified in Freiburg Ia had a higher prevalence of granulomatous diseases (P = 0·0034). The previously published associations with autoimmune diseases could not be confirmed. The Euroclass classification was not predictive of clinical phenotypes. The absolute numbers of all B cell subsets were reduced in CVID patients compared to controls. There was a significant linear correlation between low absolute total B cells and MBC with granulomatous disease (P < 0·05) and a trend towards lower B cells in patients with autoimmune diseases (P = 0·07). Absolute number of different B cell subsets may be more meaningful than their relative percentages in assessing the risk of granulomatous diseases and possibly autoimmunity.
    Clinical & Experimental Immunology 02/2012; 167(2):275-81. · 3.41 Impact Factor
  • Source
    Mahmood Al Kindi, Vidya Limaye, Pravin Hissaria
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute rhabdomyolysis is a clinical and laboratory syndrome resulting from the breakdown of skeletal muscle, with the release of intracellular contents into the circulatory system, which can cause potentially lethal complications. Here, we present the case of a patient who developed acute rhabdomyolysis after consumption of meloxicam for jaw pain and experienced generalized myalgias in the context of an acute febrile illness with generalized urticaria. Further investigation indicated elevated muscle enzymes and acute renal failure. Serological analysis revealed that the patient was positive for Ross River virus (RRV) IgM. Genetic studies to detect CYP2C9 polymorphisms were negative. Meloxicam was discontinued. He responded to conservative measures within 2 weeks. Oral aspirin challenge was negative, suggesting a drug-specific effect of meloxicam rather than a class effect. Our case indicates a causative role for meloxicam and/or acute RRV in rhabdomyolysis.
    Allergy, asthma & immunology research 01/2012; 4(1):52-4. · 2.65 Impact Factor

Publication Stats

6 Citations
6.06 Total Impact Points

Institutions

  • 2012
    • Royal Adelaide Hospital
      • Department of Clinical Immunology and Allergy
      Tarndarnya, South Australia, Australia
    • University of Adelaide
      Tarndarnya, South Australia, Australia